HCAT — Health Catalyst Cashflow Statement
0.000.00%
Last trade - 00:00
- $353.13m
- $263.44m
- $295.94m
- 55
- 57
- 48
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -60.1 | -115 | -153 | -137 | -118 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 22.5 | 75.2 | 95.1 | 72.3 | 56.5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.82 | -3.83 | 4.62 | -13.9 | -13.7 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -32.2 | -26.1 | -23.1 | -35.3 | -33.1 |
Capital Expenditures | -4.33 | -10.5 | -18.5 | -17.4 | -14.3 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Software Development Costs | |||||
Other Investing Cash Flow Items | -205 | -72.1 | -121 | -21.6 | 34.6 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -210 | -82.6 | -140 | -39 | 20.3 |
Financing Cash Flow Items | 40.8 | -1.62 | -6.29 | -1.34 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 231 | 183 | 264 | -2.61 | 2.73 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -10.4 | 73.9 | 101 | -76.9 | -10 |